MedPath

浙江巨泰药业有限公司

Ownership
-
Established
1997-03-19
Employees
-
Market Cap
-
Website
www.zjjtyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

86

NMPA:86

Drug Approvals

Amoxicillin Capsules

Product Name
阿莫西林胶囊
Approval Number
国药准字H33021728
Approval Date
Sep 3, 2024
NMPA

Xylitol Tablets

Product Name
木糖醇片
Approval Number
国药准字H33021819
Approval Date
Aug 23, 2024
NMPA

Xylitol Tablets

Product Name
木糖醇片
Approval Number
国药准字H33021818
Approval Date
Aug 23, 2024
NMPA

Cefixime Tablets

Product Name
头孢克肟片
Approval Number
国药准字H20031227
Approval Date
Aug 23, 2024
NMPA

Erythromycin Ethylsuccinate Granules

Product Name
琥乙红霉素颗粒
Approval Number
国药准字H33020999
Approval Date
Aug 23, 2024
NMPA

Cefdinir Capsules

Product Name
头孢地尼胶囊
Approval Number
国药准字H20133031
Approval Date
May 29, 2023
NMPA

Cefoxitin Sodium for Injection

Product Name
注射用头孢西丁钠
Approval Number
国药准字H20084162
Approval Date
Mar 10, 2023
NMPA

Cefoxitin Sodium for Injection

Product Name
注射用头孢西丁钠
Approval Number
国药准字H20084163
Approval Date
Feb 28, 2023
NMPA

Amoxicillin Granules

Product Name
阿莫西林颗粒
Approval Number
国药准字H20174096
Approval Date
Jul 13, 2022
NMPA

Flucloxacillin Sodium for Injection

Product Name
注射用氟氯西林钠
Approval Number
国药准字H20223217
Approval Date
Apr 8, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.